Louisiana State University, Department of Biological Sciences, Baton Rouge, Louisiana
Received 28 August 2002/ Returned for modification 10 October 2002/ Accepted 20 November 2002
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
While the extent of infection in both disease states is reliant upon the expression of numerous virulence factors, the negatively charged polysaccharide capsule has been shown to protect this organism from the immune system in animal models (31). As a result, the expression of capsular polysaccharide (CPS) is believed to be a primary virulence factor of V. vulnificus that is essential for pathogenicity. Although clinical strains of V. vulnificus are encapsulated, the ability to express CPS is often lost, as witnessed in the laboratory, resulting in a nonencapsulated spontaneous mutant that is no longer virulent and appears translucent. Nomenclature commonly used in the laboratory and herein to describe colony morphology is that of opaque (O) for an encapsulated strain and translucent (T) for a nonencapsulated strain. The event leading to or resulting in the loss of capsule expression is not understood; it is seemingly a spontaneous, random happening that can be visualized on the surface of an agar plate.
The capsule of V. vulnificus has been partially described, both phenotypically and genetically. Multiple capsule types exist, with the carbohydrate composition characteristically acidic, containing many amino sugars, including galactosamine, fucosamine, glucosamine, and quinovosamine (7). The repeating unit is believed to consist of four sugars, with common residues shared among encapsulated strains expressing different capsule types (24). Recently, Wright et al. (37) identified a genetic locus that encodes the transport of a group 1-like CPS in an encapsulated strain of V. vulnificus. Because of these previous studies, it is anticipated that the capsule gene complex of V. vulnificus is comprised of genes that correspond to previously defined characteristics of the CPS, such as carbohydrate composition and grouping.
We proposed to locate the capsule gene complex by using transposon mutagenesis. Selection and genetic analysis of four nonencapsulated transposon mutants has led to the identification of two types of loci. Numerous genes involved in capsular synthesis and expression have been identified which do correspond to possible capsule typing and phenotypic characteristics. In addition, an integron-like region has been located, similar to that of the super integron of V. cholerae.
| MATERIALS AND METHODS |
|---|
|
|
|---|
MCR (New England Biolabs, Inc., Beverly, Mass.). Cloning of essential capsule genes. The method of Chan and Goodwin (8) was used to isolate genomic DNA, with the exclusion of cetyltrimethylammonium bromide for isolation from nonencapsulated cells. Plasmid DNA was purified by using a Perfect Prep plasmid isolation kit (5 Prime, 3 Prime, Inc., Boulder, Colo.). Transposon insertion into the V. vulnificus chromosome was verified by Southern blotting with a digoxigenin-labeled probe, as described previously (40). Following digestion, the genetic regions harboring the transposon and flanking chromosomal DNA were excised from an agarose gel, purified, and cloned into pBluescript SK(-). Enzymes used for cloning included EcoRI for mutants ABZ1(T), RJS2(T), and TDB3(T) and XbaI for mutant GMB4(T).
Nucleotide sequencing. The nucleotide sequencing of V. vulnificus chromosomal DNA was determined by using the ABI PRISM Dye Terminator Cycle Sequencing Ready Reaction kit (Perkin-Elmer, Foster City, Calif.). Following amplification, each sample was purified by using the Centrisep spin columns (Princeton Separation, Adelphia, N.J.). The ABI 310 (Perkin-Elmer) genetic analyzer was utilized for determination of nucleotide sequences.
Analysis of derived sequences. Translation from nucleotide to amino acid sequences and location of open reading frames (ORFs) was performed by using the Clone Program (Science and Educational Software, Durham, N.C.). As the sequence of each clone (described above) was obtained, the Basic Localization Alignment Search Tool (BLAST) (1) was employed to assess each. Both nucleotide and protein sequences were submitted for analysis and potential identification of each ORF. Prediction of protein transmembrane regions and protein sequence analysis was performed by using Tmpred (15) and NPS@:Network Protein Sequence Analysis (10). Recognition of promoter sequences was performed by using Promoter Locator (27).
Pulsed-field gel electrophoresis. Pulsed-field gel electrophoresis (PFGE) employed a modified version of that described by Maslanka et al. (19). Digested chromosomal DNA fragments were separated by electrophoresis by using a CHEF MAPPER (Bio-Rad Laboratories). A constant temperature of 14°C was used, and electrophoresis parameters included a voltage of 6 V/cm, an angle of 120, and switch time of 2.91 to 17.33 s for 18 h. Gels were stained with ethidium bromide and were visualized on the Gel Doc 2000 (Bio-Rad). The size of DNA fragments were determined by direct comparison to the CDC PulseNet standard G5244, which was run adjacent to V. vulnificus DNA (data not shown).
Southern blot analysis and chromosomal mapping. Digoxigenin-labeled probes complementary to selected ORFs were synthesized with the primers listed in Table 1. Each recognized a representative region from each of the four gene clusters. Blotting conditions were identical for each of the probes, with a hybridization temperature of 54°C.
|
Nucleotide sequence accession numbers. The nucleotide sequences of all putative capsule genes identified in this study have been submitted to GenBank and can be obtained with accession numbers AY097060, AY096104, AY096105, AF499931, AF499932.
| RESULTS |
|---|
|
|
|---|
Nucleotide sequencing and analysis. The nucleotide sequence of V. vulnificus chromosomal DNA flanking the transposon insertion was determined for each of the four clones. The T7 and T3 primer sequences of pBluescript SK(-) vector were each utilized for nucleotide sequencing. Subsequent translation and arrangement of ORFs is shown in Fig. 1. Table 2 shows the extent of homology of these V. vulnificus ORFs to genes of heterologous bacterial species.
|
|
The imperfect direct repeats (VVR, for V. vulnificus repeats) identified in p44XBS are unique to V. vulnificus. The nucleotide sequence of VVR1 is made up of 5'-CATAACGCTGCGTTAAGGGGTGARTGCCGCCTAAACCAASYTTCCGCAGRCCACTTTCACCACTAAAACTCACCGCATACCAAAAATGCCACGCGGCAYGAATCCCACTTGAACGCCTTGTTATGYTTAAGMYTCAAWGGGTTAMGTTTTACSRTA-3'. A second set of VVR, VVR2, is also present in this genetic region. The nucleotide sequence of VVR2 is 5'-ACAAGGCGTTYAAGWGGGATTCATGCCGCGTGGCA TTTTTGGTATGCGGTGAKTWTTGGYGGTGAAAGTG GTCTGCGGAAAGYTGGTTTAKGCGGCATTCACCC CTTAACGCAGCGTTA-3'.
In addition to the VVRs, two Vibrio cholerae repeats (VCR) (13) are also present but are in the opposite orientation of the VVRs. The VCR repeats found in this region, VCR 1 and VCR 9, are also direct repeats. Furthermore, this insert contains repeats of homology, of greater than 90% in most cases, to cassette regions identified as part of super integron regions (14, 30).
IS492 transposition. Results of Southern blotting with a digoxigenin-labeled IS492-specific probe is demonstrated in Fig. 3. IS492 could be located several times throughout the V. vulnificus chromosome. Also shown are the sites of insertion that differ within the genomes of 1003(O) and 1003(T), resulting in fragment length polymorphisms.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Genes essential for encapsulation and virulence. The insertion of the mini-Tn10 transposon into wcvA, wcvF, wcvI, and orf4 rendered the wild-type V. vulnificus 1003(O) nonencapsulated, suggesting each is vital to capsule expression. While genes homologous to wcvA that encode nucleotide-sugar epimerase protein products have been linked to polysaccharide precursor synthesis (capsule and O-antigen), it has been previously proven essential to the expression of capsule polysaccharide (40). wcvF, a rhamnosyl transferase (Genbank accession no. AAC70778), is believed to be involved in the serotype-specific synthesis of extracellular polysaccharide capsule. wcvI, a glycosyl transferase, has been reported to be essential for capsule synthesis in Klebsiella pneumoniae (2). Lastly, orf4 remains undefined. While the reason for the loss of capsule expression following inactivation of orf4 is unknown, its location relative to IS492 and direct repeat sequences may provide insight as to its role in regulation of capsule synthesis and expression. Insertional inactivation of each ORF by transposon mutagenesis negated capsular expression directly or indirectly.
Mutation in each of the loci has also been shown to render the mutants avirulent (Table 3). Multiple studies have shown the increase of pathogenicity of V. vulnificus in the presence of excess serum iron, which mimics the usual immunocompromised human host. The ability of V. vulnificus to acquire iron allows the organism to thrive (31) and dramatically reduces the LD50 of a virulent organism. The iron mouse model of Wright et al. (36) is commonly used to demonstrate the enhanced virulence of V. vulnificus in the presence of excess serum iron in vivo. However, herein the iron mouse model has successfully demonstrated that the loss of capsule via transposon mutagenesis corresponds to the loss of virulence, even in the presence of excess iron.
Nucleotide sugar biosynthesis genes. Six ORFs were identified as being involved in the biosynthesis of activated monosaccharide precursors. The proposed function of each is based on sequence similarity to homologues involved in polysaccharide synthesis of various encapsulated bacteria. The nucleotide sugar epimerase wcvA and nucleotide sugar dehydrogenase wcvB were identified as proximal ORFs of the same orientation. Although it seems likely that these two ORFs could be polycistronic, the Promoter Locator (27) suggests that individual promoter regions and transcriptional start sites for each wcvA and wcvB exist. Therefore, independent expression of each cannot be ruled out.
Three rml genes, rmlA, rmlD, and rmlC, involved in the biosynthesis of L-rhamnose, were identified and located in tandem in the same transcriptional orientation at the 5' end of p54BS. It is not known whether a promoter region is present upstream of rmlA for transcription of a polycistronic message, but the absence of a promoter in the few bases that separate each of the tightly linked ORFs suggests it is transcribed in such a manner. The presence of these genes is not surprising considering that L-rhamnose was the most common sugar identified as a component of V. vulnificus polysaccharide capsules (7). Because these three genes are known to be part of a four-gene cluster, it is possible that rmlB, while not detected, is most likely positioned upstream and was excised upon being cloned with EcoRI.
wcvH is also believed to mediate the biosynthesis of activated monosaccharide precursors. WcvH in V. vulnificus is homologous to cps19bR, which is encoded by a sequence located within the serotype-specific region of the capsule gene cluster of Streptococcus pneumoniae (21).
Polymerization and processing genes. In the Wzy-dependent system, a glycosyltransferase (WecA) initiates transfer of activated individual repeat unit precursors, such as GlcNac-1-phosphate, to an undecaprenyl phosphate lipid carrier. This is necessary for building repeating polysaccharide units. Continuing the process, a flippase (Wzx) translocates the repeat units across the cytoplasmic membrane. The repeat sugar units are then polymerized by Wzy. Figure 1 shows the presence of wecA, wzx, and wzy, which suggests the capsule is lipid-linked and Wzy-dependent. GlcNAc and GalNAc are both identified among the four sugar repeating subunits of polysaccharide capsules of V. vulnificus (7, 25), which may be the result of the Wzy-dependent system.
These genes which participate in assembly and transport of repeat sugar units are believed to be serotype specific because they are exacting for the sugars and the glycosidic linkages that join the repeats to confer serological specificity. They are located within the polysaccharide-specific regions of gene clusters in heterologous encapsulated bacteria and are believed to be involved in both K- and O-antigen synthesis (23).
Additional transferase genes. In addition to the initiating glycosyltransferase (wecA) activity, wcvE, wcvF, wcvG, and wcvI are also believed to encode glycosyltransferase enzymes. Both wcvF and wcvI were disrupted by the transposon, resulting in the loss of capsule expression in V. vulnificus. Since the predicted function of each precise transferase was based on sequence homologies, individual substrates are not known except for that of wcvF, which is believed to encode a rhamnosyl transferase.
Insertion sequences.
Three ORFs homologous to insertion sequences were identified within two regions of the V. vulnificus chromosome. pEpiBS contained both
IS1358 and IS3 in tandem. It is possible that IS3 had inserted into this genetic region, rendering both IS1358 and wcvA truncated. However, the ability of IS3 to transpose throughout the V. vulnificus genome remains undetermined.
IS1358 is believed to be involved in homologous recombination of polysaccharide genetic loci (4). Genetic exchange mediated by IS1358 has been hypothesized at an interspecies level among the Vibrio species (32), and it has been shown to transpose at a frequency comparable to those of other insertion sequences (12).
The IS492 element was located in the genetic region cloned in p44XBS (Fig. 1D). IS492 can reversibly inactivate extracellular polysaccharide synthesis in Pseudomonas atlantica, where insertion is site-specific (ACAAG), and excision from the eps gene restores polysaccharide production (3). Analogous to that seen with P. atlantica, Southern blot analysis (Fig. 3) showed that IS492 is found numerous times in the V. vulnificus genome. Blotting also showed that the sites for insertion of IS492 differ among the encapsulated and nonencapsulated morphotypes of V. vulnificus strain 1003. Furthermore, PFGE analysis, shown in Fig. 2B, demonstrates that the repeats of IS492 are confined to a single 330-Kbp chromosomal region in 1003(O) and a single 260-Kbp fragment in 1003(T). These differences in banding patterns of encapsulated versus nonencapsulated strains indicates a genomic rearrangement in V. vulnificus.
Generally, insertion sequence elements have frequently been located near polysaccharide gene loci and are believed to generate polymorphisms seen within a bacterial species due to recombination. Often capsule gene clusters in E. coli strains are flanked by insertion sequence elements. They may mediate genetic transfer among heterologous strains which produces antigenic diversity (23). The presence of recognizable insertion sequences in the V. vulnificus genome suggests that recombination may occur and may explain restriction fragment length polymorphisms observed within the V. vulnificus species.
Undefined ORFs and repeat regions. The genomic region cloned in p44XBS contained four ORFs that were not homologous to any nucleotide or amino acid sequence when subjected to BLAST (1) analysis. Therefore, no function can be assigned to the four ORFs on the basis of sequence homology. Further analysis of each ORF provided a limited protein profile for each. Orf3 is the only protein of the four analyzed that possesses transmembrane regions. It has two strong transmembrane helices at amino acids 9 to 27 and 50 to 69, with no other notable chemical characteristics. While the region between VCR 9 and orf4 remains unidentified, insertion of the transposon at the 3' end of orf4 demonstrates an essential role in capsule expression. Orf4 was shown to be hydrophilic in nature, with a predicted alpha helix. The inferred products for the remaining two ORFs possessed no recognizable motifs or characteristics.
The identification of multiple unidentified ORFs in combination with flanking direct repeats is reminiscent of the arrangement of integron-gene cassette regions of super integrons (30). Mazel et al. (19) detected 60 to 100 copies of VCRs within a single locus of the V. cholerae genome, comprising what is thought to be a super integron. VCR cassettes are intergenic regions that have been linked to super integrons located on the smaller of two V. cholerae chromosomes. These repeat regions are thought to be the target of site-specific insertion for acquisition of exogenous DNA, mostly consisting of ORFs with no identified homologues (30), such as orf1. Characteristics of the integron-gene cassette include imperfect direct repeats that flank a single ORF. This mimics the gene cassette array found in antibiotic resistance-encoding integrons and is believed to be a system for acquiring new genes via site-specific recombination in V. cholerae (19). Integrase-mediated recombination between VCRs has been reported previously (9) and results in the acquisition of ORFs with no homologues identified by using database alignment (30). This system was also identified in Vibrio metschnikovii, Vibrio parahaemolyticus, and Vibrio fischeri and appears to be present in V. vulnificus. Regions homologous to the VCR sequences (VCR 1 and VCR 9) which flanked undefined ORFs were located within the V. vulnificus genomic region cloned in p44XBS. The presence of the VCR and VVR direct repeats in combination with the undefined ORF cassettes in p44XBS suggested that the presence of the integron-gene cassette is a possibility. The acquisition of cassette regions is implied by the G+C content of orf1234, which ranges from 36 to 42%, similar to that of the gene-VCR cassettes of V. cholerae (19). Because these values are lower than those of V. vulnificus chromosomal DNA, documented as 45 to 48% (29), it is possible that these ORFs were acquired via site-specific recombination. In addition, similar to the arrangement of the V. cholerae super integron, results of PFGE and Southern blotting positioned the VCR (and VVR) cassettes and undefined ORFs within a single locus of the V. vulnificus chromosome (Fig. 2B). This further enhances the likelihood for the presence of a super integron in V. vulnificus.
Chromosomal linkage. The V. vulnificus chromosomal DNA that flanked the transposon insertion of each of the four clones is believed to be part of a capsule gene locus. Although the four genetic regions do not overlap to allow chromosomal walking, the relative proximity of each within the V. vulnificus genome was demonstrated by PFGE and Southern blotting analysis. ORFs within clones pEpiBS, p47BS, and p54BS are located on the same 200-Kbp chromosomal fragment (Fig. 2B). The location of genes wcvA, wcvF, and wcvI remained unchanged, even following an unexplained genetic switch observed when comparing the genome of 1003(O) to that of the spontaneously acquired nonencapsulated 1003(T). The constant position of these loci in 1003(O) and 1003(T) indicate that the arrangement of the three capsule gene regions are not affected in the genetic rearrangement of 1003(T).
IS492 is identified as a mobilizable insertion sequence element in P. atlantica. It is capable of inserting into capsule genes to cause the loss of capsule production and then excise itself, permitting the organism to revert back to the encapsulated state (3). PFGE shows that the 330-Kbp chromosomal fragment harboring IS492 in V. vulnificus 1003(O) is shifted in 1003(T) to a 260-Kbp fragment (Fig. 2B). Both orf1 and VCR 9, in conjunction with IS492, were also located on the shifted band of 1003(T) by Southern blot analysis (data not shown). While the cause for the band shift and its relation to loss of capsule expression is unknown, it is logical to recognize the fact that IS492 is located proximal to unidentified ORFs, numerous repeat regions, and stretches of DNA similar to integron cassettes, all located on a single chromosomal fragment. These qualities are characteristic features of the super integrons in V. cholerae and other Vibrio species (19, 30). Collectively, this integron-like region is not believed to be a part of the capsule gene cluster. It follows that the products of this genetic region do not contribute directly to the biosynthesis, polymerization, or transport of the polysaccharide capsule. Instead, disruption of orf4 may have affected capsule expression negatively via an indirect means.
General organization. Identification of each ORF via sequence similarity to homologues has helped develop an understanding of the organizational arrangement of the capsule genes in V. vulnificus. This arrangement provides insight for classification of the V. vulnificus capsule (K-antigen) according to the four defined capsule groups (35). These are defined by E. coli groups I (IA and IB), II, and, more recently, III (16). A recent reclassification proposed by Whitfield and Roberts (35) placed group IB into a fourth independent group. The polysaccharide genes described in this study place V. vulnificus capsule with both groups 1 and 4 according to the newly described guidelines for the following reasons. The identification of both wzx and wzy indicates that polymerization and transmembrane export is Wzy-dependent, an event and property common to groups 1 and 4. However, the initiating glycosyltransferase involved in this Wzy-dependent system is wecA, which characterizes group 4 (35). With additional properties that distinguish groups 1 and 4 remaining unknown for V. vulnificus, such as regulatory systems and nearby genetic loci, the correct grouping of this capsule gene cluster cannot be determined with certainty at this juncture. The identification of wecA, wzx, and wzy in V. vulnificus has indicated that the polysaccharide capsule of V. vulnificus is lipid linked, analogous to the attachment of lipopolysaccharide synthesis. This concurs with the findings of Wright et al. (37), which identified wza as part of the capsule gene locus and indicates a lipid-linked capsule polysaccharide as well.
Conclusion. With the capsular carbohydrate composition of V. vulnificus known to be acidic and to contain many amino sugars (7, 25), the regions identified provide a genetic basis for further understanding of the K-antigen. The identification of the Wzy-dependent system suggests the capsule polysaccharide is lipid linked. In addition, the genetic regions of the capsule gene locus of strain 1003(O) may also be used in conjunction with V. vulnificus capsule genes previously identified, such as wza (37).
It should be noted that ORFs known to contribute to CPS synthesis and expression in heterologous bacteria may also contribute to LPS synthesis and expression, as both antigens are comprised of repeating polysaccharide units. The genes involved in polysaccharide biosynthesis, polymerization, and transport may naturally be shared among both processes. However, because virulence studies have shown a correlation of opaque colony morphology and virulence, it is believed that the CPS protects the organism from the host immune system, acting as an essential virulence factor (31). The study herein has illustrated this concept, as translucent mutants were no longer virulent with the iron mouse model. The contribution of the ORFs (Table 2) to LPS expression is a viable possibility and must not be ruled out. Such analysis may provide a more complete understanding of polysaccharide synthesis and expression.
With numerous possibilities for employment of the data presented, the insertion sequence elements, capsule polysaccharide genes, and integron-gene cassette region described in this study can hopefully provide a further understanding of V. vulnificus genetics and antigenic diversity.
| ACKNOWLEDGMENTS |
|---|
We thank V. R. Srinivasan, Gregg Pettis, and Richard Cooper for their guidance and support. Many thanks to Chupon Shariffskul and Paul Fiorella for assistance with PFGE protocols.
| FOOTNOTES |
|---|
This paper is dedicated to the memory of Ron Siebeling, an exceptional microbiologist, professor, and mentor. ![]()
| REFERENCES |
|---|
|
|
|---|
| 1. | Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.[CrossRef][Medline] |
| 2. | Arakawa, Y., R. Wacharotayankun, T. Nagatsuka, H. Ito, N. Kato, and M. Ohta. 1995. Genomic Organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J. Bacteriol. 177:1788-1796. |
| 3. | Bartlett, D. H., and M. Silverman. 1989. Nucleotide sequence of IS492, a novel insertion sequence causing variation in extracellular polysaccharide production in the marine bacterium Pseudomonas atlantica. J. Bacteriol. 171:1763-1766. |
| 4. | Bik, E. M., A. E. Bunschoten, R. D. Gouw, and F. R. Mooi. 1995. Genesis of the novel epidemic Vibrio cholerae O139 strain: evidence for horizontal transfer of genes involved in polysaccharide synthesis. EMBO J. 14:209-216.[Medline] |
| 5. | Blake, P. A., M. H. Merson, R. E. Weaver, D. G. Hollis, and P. C. Heublin. 1979. Disease caused by a marine vibrio: clinical characteristics and epidemiology. N. Engl. J. Med. 300:1-5.[Abstract] |
| 6. | Blattner, F. R., G. Plunkett III, C. A. Block, N. T. Perna, et al. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453-1474. |
| 7. | Bush, C. A., P. Patel, S. Gunawardena, J. Powell, A. Joseph, J. A. Johnson, and J. G. Morris. 1997. Classification of Vibrio vulnificus strains by the carbohydrate composition of their capsular polysaccharides. Anal. Biochem. 250:186-195.[CrossRef][Medline] |
| 8. | Chan, J. W. Y. F., and P. H. Goodwin. 1995. Extraction of genomic DNA from extracellular polysaccharide-synthesizing gram-negative bacteria. BioTechniques 18:418-422.[Medline] |
| 9. | Clark, C. A., L. Purins, P. Kaewrakon, T. Focareta, and P. A. Manning. 2000. The Vibrio cholerae O1 chromosomal integron. Genet. Mol. Biol. 146:2605-2612. |
| 10. | Combet, C., C. Blanchet, C. Geourjon, ad G. Deleage. 2000. NPS@: network protein sequence analysis. Trends Biochem. Sci. 25:147-150.[CrossRef][Medline] |
| 11. | Comstock, L. E., M. J. Coyne, A. O. Tzianabos, A. Pantosti, A. B. Onderdonk, and D. L. Kasper. 1999. Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect. Immun. 67:3525-3532. |
| 12. | Dumontier, S., P. Trier-Cuot, and P. Berche. 1998. Structural and functional characterization of IS1358 from Vibrio cholerae. J. Bacteriol. 180:6101-6106. |
| 13. | Franzon, V. L., A. Barker, and P. A. Manning. 1993. Nucleotide sequence encoding the mannose-ducose-resistant hemagglutinin of Vibrio cholerae O1 and construction of a mutant. Infect. Immun. 61:3032-3037. |
| 14. | Heidelberg, J. F., et al. 2000. DNA Sequence of both chromosomes of the cholera pathogen. Nature 406:477-483.[CrossRef][Medline] |
| 15. | Hofmann, K., and W. Stoffel. 1993. Tmbase-a database of membrane spanning proteins segments. Biol. Chem. Hoppe-Seyler. 374:166. |
| 16. | Jann, B., and K. Jann. 1997. Capsules of Escherichia coli. In M. Sussman (ed.), Escherichia coli mechanisms of virulence, p. 113-143. Cambridge University Press, Cambridge, United Kingdom. |
| 17. | Lin, W. S., T. Cunneen, and C. Y. Lee. 1994. Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus. J. Bacteriol. 176:7005-7016. |
| 18. | Makino, K., K. Yokoyama, Y. Kubota, C. H. Yutsudo, S. Kimura, K. Kurokawa, K. Ishii, M. Hattori, I. Tatsuno, H. Abe, T. Iida, K. Yamamoto, M. Ohnishi, T. Hayashi, T. Yasunaga, T. Honda, C. Sasakawa, and H. Shinagawa. 1999. Complete nucleotide sequence of the prophage BT2-Sakai carrying the verotoxin 2 genes of the enterohemorrhagic Escherichia coli O157:H7 derived from the Sakai outbreak. Genes Genet. Syst. 74:227-239.[CrossRef][Medline] |
| 19. | Maslanka, S. E., J. G. Kerr, G. Williams, J. M. Barbaree, L. A. Carson, J. M. Miller, and B. Swaminathan. 1999. Molecular subtyping of Clostridium perfringens by pulsed-field gel electrophoresis to facilitate food-borne-disease outbreak investigations. J. Clin. Microbiol. 37:2209-2214. |
| 20. | Mazel, D., B. Dychinco, V. A. Webb, and J. Davies. 1998. a distinctive class of integron in the Vibrio cholerae genome. Science 280:605-608. |
| 21. | Morona, J. K., R. Morona, and J. C. Paton. 1997. Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcus pneumoniae type 19B. J. Bacteriol. 179:4953-4958. |
| 22. | Nakano, Y., Y. Yoshida, Y. Yamashita, and T. Koga. 1998. A gene cluster for 6-deoxy-L-talan synthesis in Actinobacillus actinomycetemcomitans. Biochim. Biophys. Acta 1442:409-414.[Medline] |
| 23. | Rahn, A., J. Drummelsmith, and C. Whitfield. 1999. Conserved organization in the cps gene clusters for expression of Escherichia coli group 1 K antigens: relationship to the colanic acid biosynthesis locus and the cps genes from Klebsiella pneumoniae. J. Bacteriol. 181:2307-2313. |
| 24. | Reddy, G. P., U. Hayat, C. Abeygunawardana, C. Fox, A. C. Wright, D. R. Maneval, Jr., C. A. Bush, and J. G. Morris, Jr. 1992. Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24. J. Bacteriol. 174:2620-2630. |
| 25. | Reddy, G. P., U. Hayat, Q. Xu, K. V. Reddy, Y. Wang, K. W. Chiu, J. G. Morris, Jr., and C. A. Bush. 1998. Structure determination of the capsular polysaccharide from Vibrio vulnificus strain 6353. Eur. J. Biochem. 255:279-288.[Medline] |
| 26. | Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:493-497. |
| 27. | Reese, M. G. 2001. Application of a time-delay neural network to promoter annotation in the Drosophila melangaster genome. Comput. Chem. 26:51-56.[CrossRef][Medline] |
| 28. | Reeves, P. R., M. Hobbs, M. A. Valvano, M. Skurnik, C. Whitfield, D. Coplin, N. Kido, J. Klena, D. Maskell, C. R. H. Raetz, and P. D. Rick. 1996. Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol. 4:495-503.[CrossRef][Medline] |
| 29. | Reichelt, J. L., P. Baumann, and L. Baumann. 1976. Study of genetic relationships among marine species of the genera Benechea and Photobacterium by means of in vitro DNA/DNA hybridization. Arch. Microbiol. 110:101-120.[CrossRef][Medline] |
| 30. | Rowe-Magnus, D. A., A. Guerout, and D. Mazel. 2001. The evolutionary history of chromosomal super-integron ancestry for multiresistant integrons. Proc. Natl. Acad. Sci. USA 98:652-657. |
| 31. | Simpson, L. M., V. K. White, S. F. Zane, and J. D. Oliver. 1987. Correlation between virulence and colony morphology in Vibrio vulnificus. Infect. Immun. 55:269-272. |
| 32. | Stroeher, U. H., K. E. Jedani, and P. A. Manning. 1998. Genetic organization of the regions associated with surface polysaccharide synthesis in Vibrio cholerae O1, O139 and Vibrio anguillarum O1 and O2: a review. Gene 223:269-282.[CrossRef][Medline] |
| 33. | Wang, L., C. E. Briggs, D. Rothemund, P. Fratamico, J. B. Luchansky, and P. R. Reeves. 2001. Sequence of the E. coli O104 antigen gene cluster and identification of O104 specific genes. Gene 270:231-236.[CrossRef][Medline] |
| 34. | White, O., J. A. Eisen, J. F. Heidelberg, E. K. Hickey, J. D. Peterson, R. J. Dodson, D. H. Haft, M. L. Gwinn, W. C. Nelson, et al. 1999. Genome sequence of the radioresistant bacterium Deinococcus radiodurans R1. Science 286:1571-1577. |
| 35. | Whitfield, C., and I. S. Roberts. 1999. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol. Microbiol. 31:1307-1319.[CrossRef][Medline] |
| 36. | Wright, A. C., L. M. Simpson, and J. D. Oliver. 1981. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect. Immun. 34:503-507. |
| 37. | Wright, A. C., J. L. Powell, J. B. Kaper, and J. G. Morris, Jr. 2001. Identification of a group 1-like capsular polysaccharide operon for Vibrio vulnificus. Infect. Immun. 69:6893-6901. |
| 38. | Yamasaki, S., T. Shimizu, K. Hoshino, S. T. Ho, T. Shimada, G. B. Nair, and Y. Takeda. 1999. The genes responsible for O-antigen synthesis of Vibrio cholerae O139 are closely related to those of Vibrio cholerae O22. Gene 237:321-332.[CrossRef][Medline] |
| 39. | Yoshida, Y., Y. Nakano, N. Suzuki, H. Nakao, Y. Yamashita, and T. Koga. 1999. Genetic analysis of the gene cluster responsible for synthesis of serotype e-specific polysaccharide antigen in Actinobacillus actinomycetemcomitans. Biochim. Biophys. Acta 1489:457-461.[Medline] |
| 40. | Zuppardo, A. B., and R. J. Siebeling. 1998. An epimerase gene essential for capsule synthesis of Vibrio vulnificus. Infect. Immun. 66:2601-2606. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|